(Q40205540)

18 September 2017

title

Dissection of signaling pathways in fourteen breast cancer cell lines using reverse-phase protein lysate microarray (English)

1 reference

18 September 2017

M Akkiprik

1

1 reference

18 September 2017

D Nicorici

2

1 reference

18 September 2017

D Cogdell

3

1 reference

18 September 2017

Y J Jia

4

1 reference

18 September 2017

A Hategan

5

1 reference

18 September 2017

I Tabus

6

1 reference

18 September 2017

O Yli-Harja

7

1 reference

18 September 2017

D Y

8

1 reference

18 September 2017

A Sahin

9

1 reference

18 September 2017

W Zhang

10

1 reference

18 September 2017

publication date

1 December 2006

1 reference

Technology in Cancer Research and Treatment

18 September 2017

published in

1 reference

18 September 2017

volume

5

1 reference

18 September 2017

issue

6

1 reference

18 September 2017

page(s)

543-551

1 reference

Protein microarrays: Promising tools for proteomic research

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

Controlling the false discovery rate in behavior genetics research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

Statistical significance for genomewide studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

Array-based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

The association between Akt activation and resistance to hormone therapy in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

Akt is frequently activated in HER2/neu-positive breast cancers and associated with poor prognosis among hormone-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

Insulin-Like Growth Factor Binding Protein Secretion by Breast Carcinoma Cell Lines: Correlation with Estrogen Receptor Status*

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

Insulin-like growth factor-binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

Differential IGF-independent effects of insulin-like growth factor binding proteins (1-6) on apoptosis of breast epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity i

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460600500601

10.1177/153303460600500601

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference